Fulgent Genetics, Inc. — Director's Dealing 2022

May 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2022-05-19

Reporting Person: Xie Jian (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-19	Common Stock	S	10000	$58.2866	Disposed	319701	Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $57.5100 to $59.4350, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.